LEP and type 1 diabetes mellitus: Given that overweight patients with type 1 diabetes are already hyperleptinemic [44,45,46], the findings of this study suggest that the enhancement of leptin signaling in the hypothalamic ARC using liraglutide treatment may contribute to weight loss and improved glucose metabolism.